Efficacy of Low-Dose Continuous Infusion of Human Atrial Natriuretic Peptide (hANP) During Lung Resection Surgery

Efficacy of Low-Dose Continuous Infusion of Human Atrial Natriuretic Peptide (hANP) During Lung Resection Surgery - Efficacy of hANP During Lung Resection Surgery

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001524

Enrollment

Registered

2009-07-05

Start date

2008-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Resection Surgery

Interventions

Low-dose continuous infusion of hANP group Control group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo pulmonary resections and preoperative BNP of 30pg/mL or more

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
whether infusion of hANP during pulmonary resection has an effect on the reduction of postoperative complications (atrial fibrillation)	—

Secondary

Measure	Time frame
Postoperative hemodynamics, white blood cell counts, and C-reactive protein levels	—

Countries

Japan

Contacts

Public ContactTakashi Nojiri

Toneyama National Hospital General Thoracic Surgery

honnnori2003@yahoo.co.jp06-6853-2001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026